Other Consolidated Financial Statement Detail (Tables)

6 Months Ended

Jun. 30, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Other income (expense), net

	For the Three Months Ended June 30,						For the Six Months Ended June 30,
(In millions)	2013			2012			2013			2012
Interest income	$	0.9		$	10.2		$	5.2		$	16.7
Interest expense	(7.3		)	(7.0		)	(18.9		)	(14.4		)
Impairments of investments	(1.4		)	(0.8		)	(1.7		)	(1.3		)
Gain (loss) on investments, net	5.7			2.5			10.1			14.3
Foreign exchange gains (losses), net	(5.3		)	(1.3		)	(7.9		)	0.1
Other, net	(3.0		)	(0.6		)	(11.7		)	2.7
Total other income (expense), net	$	(10.4	)	$	3.0		$	(24.9	)	$	18.1

Accrued Expenses and Other

(In millions)	As of June 30, 2013		As of December 31, 2012
Revenue-related rebates	$	218.6	$	191.0
Employee compensation and benefits	213.3		248.5
Deferred revenue	167.4		148.0
Royalties and licensing fees	113.5		45.2
Clinical development expenses	54.5		51.6
Production expenses	42.5		45.6
Construction in progress	29.3		12.3
Current portion of contingent consideration obligations	27.9		22.4
Collaboration expenses	25.9		37.4
Other	163.3		177.9
Total accrued expenses and other	$	1,056.2	$	979.9